JNJ - GSK wins FDA approval of Blenrep for multiple myeloma
2025-10-23 17:27:02 ET
More on GSK
- GSK: Compelling Value, No Red Flags Ahead Of Earnings, Blenrep FDA Decision Soon
- GSK's Hidden Growth Engines Beyond HIV And Oncology
- GSK: Walmsley Out, Miels In - I'm Watching The CEO Transition From The Sidelines
- Alector slumps on late-stage trial setback for GSK-partnered dementia candidate
- Astra, GSK up after report on U.K. – U.S. drug pricing deal